Allogeneic bone marrow transplantation for acute leukemia in adults

T. Masszi, P. Reményi, G. Kriván, V. Goda, M. Réti

Research output: Article

1 Citation (Scopus)


From September 1993 to August 1997, 24 consecutive adult acute leukemia patients (20 AML and 4 ALL) received allogeneic bone marrow transplant (21 sibling, 1 twin, 2 MUD). The probability of 3 year leukemia free survival is 19/24 (79%), the transplant related mortality is 2/24 (8%), the relapse rate is 3/24 (13%). The median follow up period is 34 months (range 7-51). Three AML patients with high probability of TRM received a special radiation-free conditioning regimen (mitobronitol/cytarabine/ cyclophosphamide) originally described by Kelemen et al in CML patients for decreasing transplant related complications. All the three patients are alive and disease free over 3 years.

Original languageEnglish
Pages (from-to)S77-S79
JournalBone Marrow Transplantation
Issue numberSUPPL. 4
Publication statusPublished - dec. 1 1998


ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Masszi, T., Reményi, P., Kriván, G., Goda, V., & Réti, M. (1998). Allogeneic bone marrow transplantation for acute leukemia in adults. Bone Marrow Transplantation, 22(SUPPL. 4), S77-S79.